Next Article in Journal
Special Issue “Chemical Speciation of Organic and Inorganic Components of Environmental and Biological Interest in Natural Fluids: Behaviour, Interaction and Sequestration”
Next Article in Special Issue
Complexes Between Adamantane Analogues B4X6 -X = {CH2, NH, O ; SiH2, PH, S} - and Dihydrogen, B4X6:nH2 (n = 1–4)
Previous Article in Journal
Essential Oil Yield and Composition of the Balkan Endemic Satureja pilosa Velen. (Lamiaceae)
Previous Article in Special Issue
Focus on Chemistry of the 10-Dioxane-nido-7,8-dicarba-undecahydrido Undecaborate Zwitterion; Exceptionally Easy Abstraction of Hydrogen Bridge and Double-Action Pathways Observed in Ring Cleavage Reactions with OH as Nucleophile
Open AccessFeature PaperReview

Boron Chemistry for Medical Applications

1
School of Pharmacy, Macau university of Science and Technology, Avenida Wai Long Taipa, Macau 999078, China
2
Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, IL 60115, USA
*
Authors to whom correspondence should be addressed.
Academic Editor: Igor B. Sivaev
Molecules 2020, 25(4), 828; https://doi.org/10.3390/molecules25040828
Received: 20 January 2020 / Revised: 7 February 2020 / Accepted: 11 February 2020 / Published: 13 February 2020
Boron compounds now have many applications in a number of fields, including Medicinal Chemistry. Although the uses of boron compounds in pharmacological science have been recognized several decades ago, surprisingly few are found in pharmaceutical drugs. The boron-containing compounds epitomize a new class for medicinal chemists to use in their drug designs. Carboranes are a class of organometallic compounds containing carbon (C), boron (B), and hydrogen (H) and are the most widely studied boron compounds in medicinal chemistry. Additionally, other boron-based compounds are of great interest, such as dodecaborate anions, metallacarboranes and metallaboranes. The boron neutron capture therapy (BNCT) has been utilized for cancer treatment from last decade, where chemotherapy and radiation have their own shortcomings. However, the improvement in the already existing (BPA and/or BSH) localized delivery agents or new tumor-targeted compounds are required before realizing the full clinical potential of BNCT. The work outlined in this short review addresses the advancements in boron containing compounds. Here, we have focused on the possible clinical implications of the new and improved boron-based biologically active compounds for BNCT that are reported to have in vivo and/or in vitro efficacy. View Full-Text
Keywords: boron chemistry; boron-containing compounds; boron cluster; carborane; boron neutron capture therapy; boron delivery agents for BNCT; medical applications boron chemistry; boron-containing compounds; boron cluster; carborane; boron neutron capture therapy; boron delivery agents for BNCT; medical applications
Show Figures

Figure 1

MDPI and ACS Style

Ali, F.; S Hosmane, N.; Zhu, Y. Boron Chemistry for Medical Applications. Molecules 2020, 25, 828.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop